159 related articles for article (PubMed ID: 1540961)
1. Immunoreactive human chorionic gonadotropin and its free beta subunit in serum and ascites of patients with malignant tumors.
Hoermann R; Gerbes AL; Spoettl G; Jüngst D; Mann K
Cancer Res; 1992 Mar; 52(6):1520-4. PubMed ID: 1540961
[TBL] [Abstract][Full Text] [Related]
2. Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms.
Marcillac I; Troalen F; Bidart JM; Ghillani P; Ribrag V; Escudier B; Malassagne B; Droz JP; Lhommé C; Rougier P
Cancer Res; 1992 Jul; 52(14):3901-7. PubMed ID: 1377600
[TBL] [Abstract][Full Text] [Related]
3. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
[TBL] [Abstract][Full Text] [Related]
4. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
[TBL] [Abstract][Full Text] [Related]
5. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE
Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the presence of human chorionic gonadotropin (hCG) and free beta-subunit of hCG in the human pituitary.
Hoermann R; Spoettl G; Moncayo R; Mann K
J Clin Endocrinol Metab; 1990 Jul; 71(1):179-86. PubMed ID: 1695224
[TBL] [Abstract][Full Text] [Related]
7. Endometrial adenocarcinoma associated with elevated serum concentrations of the free beta subunit of human chorionic gonadotropin.
Grenache DG; Moller KA; Groben PM
Am J Clin Pathol; 2004 May; 121(5):748-53. PubMed ID: 15151215
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactivity of a commercial chemiluminescence immunoassay for human chorionic gonadotropin with the free beta-subunit.
Luppa P; Spöttl G; Saller B; Neumeier D; Mann K
J Biolumin Chemilumin; 1992 Jul; 7(3):195-201. PubMed ID: 1381136
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycosylated human chorionic gonadotropin and human chorionic gonadotropin free beta-subunit: tumor markers and tumor promoters.
Cole LA; Butler SA
J Reprod Med; 2008 Jul; 53(7):499-512. PubMed ID: 18720925
[TBL] [Abstract][Full Text] [Related]
10. Measurement of human chorionic gonadotropin-related immunoreactivity in serum, ascites and tumour cysts of patients with gynaecologic malignancies.
Grossmann M; Hoermann R; Gocze PM; Ott M; Berger P; Mann K
Eur J Clin Invest; 1995 Nov; 25(11):867-73. PubMed ID: 8582453
[TBL] [Abstract][Full Text] [Related]
11. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha).
Dirnhofer S; Freund M; Rogatsch H; Krabichler S; Berger P
Hum Pathol; 2000 Aug; 31(8):966-72. PubMed ID: 10987258
[TBL] [Abstract][Full Text] [Related]
12. Phantom hCG and phantom choriocarcinoma.
Cole LA
Gynecol Oncol; 1998 Nov; 71(2):325-9. PubMed ID: 9826481
[TBL] [Abstract][Full Text] [Related]
13. Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease.
Alfthan H; Haglund C; Roberts P; Stenman UH
Cancer Res; 1992 Sep; 52(17):4628-33. PubMed ID: 1324787
[TBL] [Abstract][Full Text] [Related]
14. Human chorionic gonadotropin (hCG) and its free subunits in hydrocele fluids and neoplastic tissue of testicular cancer patients: insights into the in vivo hCG-secretion pattern.
Madersbacher S; Kratzik C; Gerth R; Dirnhofer S; Berger P
Cancer Res; 1994 Oct; 54(19):5096-100. PubMed ID: 7923124
[TBL] [Abstract][Full Text] [Related]
15. Human chorionic gonadotropin: properties and assay methods.
Tyrey L
Semin Oncol; 1995 Apr; 22(2):121-9. PubMed ID: 7740312
[TBL] [Abstract][Full Text] [Related]
16. Expression and secretion of the beta subunit of human chorionic gonadotropin by bladder carcinoma in vivo and in vitro.
Nishimura R; Koizumi T; Morisue K; Yamanaka N; Lalwani R; Yoshimura M; Nakagawa T; Shii K; Hasegawa K; Baba S
Cancer Res; 1995 Apr; 55(7):1479-84. PubMed ID: 7882356
[TBL] [Abstract][Full Text] [Related]
17. The incidence and significance of serum hCG and CEA in patients with gastrointestinal malignant tumors.
Birkenfeld S; Noiman G; Krispin M; Schwartz S; Zakut H
Eur J Surg Oncol; 1989 Apr; 15(2):103-8. PubMed ID: 2703054
[TBL] [Abstract][Full Text] [Related]
18. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
Cole LA; Butler S
J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
[TBL] [Abstract][Full Text] [Related]
19. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
Cole LA; Sutton JM
J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
[TBL] [Abstract][Full Text] [Related]
20. Human chorionic gonadotropin, its free subunits and gestational trophoblastic disease.
Ozturk M
J Reprod Med; 1991 Jan; 36(1):21-6. PubMed ID: 1706779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]